Oza, AM; Matulonis, UA; Alvarez Secord, A; Nemunaitis, J; Roman, LD; Blagden, SP; Banerjee, S; ... Matei, D; + view all <#> Oza, AM; Matulonis, UA; Alvarez Secord, A; Nemunaitis, J; Roman, LD; Blagden, SP; Banerjee, S; McGuire, WP; Ghamande, S; Birrer, MJ; Fleming, GF; Markham, MJ; Hirte, HW; Provencher, DM; Basu, B; Kristeleit, R; Armstrong, DK; Schwartz, B; Braly, P; Hall, GD; Nephew, KP; Jueliger, S; Oganesian, A; Naim, S; Hao, Y; Keer, H; Azab, M; Matei, D; - view fewer <#> (2020) A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer. Clinical Cancer Research , 26 (5) pp. 1009-1016. 10.1158/1078-0432.CCR-19-1638 <https://doi.org/10.1158/1078-0432.CCR-19-1638>. Green open access